48 related articles for article (PubMed ID: 38542414)
1. Construction and validation of a clinical risk model based on machine learning for screening characteristic factors of lymphovascular space invasion in endometrial cancer.
Wang F; Pang R; Shi S; Zhang Y
Sci Rep; 2024 Jun; 14(1):12624. PubMed ID: 38824215
[TBL] [Abstract][Full Text] [Related]
2. Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study.
Sulaiman R; Dale A; Lin X; Aske JC; Gaster K; Starks D; Espaillat LR; De P; Dey N
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542414
[TBL] [Abstract][Full Text] [Related]
3. Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.
Jorge S; Hou JY; Tergas AI; Burke WM; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 Mar; 140(3):387-93. PubMed ID: 26768835
[TBL] [Abstract][Full Text] [Related]
4. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.
Matsuo K; Garcia-Sayre J; Medeiros F; Casabar JK; Machida H; Moeini A; Roman LD
J Surg Oncol; 2015 Nov; 112(6):669-76. PubMed ID: 26391212
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
Hahn HS; Lee IH; Kim TJ; Lee KH; Shim JU; Kim JW; Lim KT
Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
[TBL] [Abstract][Full Text] [Related]
6. Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.
Zhang C; Havrilesky LJ; Broadwater G; Di Santo N; Ehrisman JA; Lee PS; Berchuck A; Alvarez Secord A; Bean S; Bentley RC; Valea FA
Gynecol Oncol; 2014 May; 133(2):211-5. PubMed ID: 24582867
[TBL] [Abstract][Full Text] [Related]
7. Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? - A single-institution study.
Pifer PM; Bhargava R; Patel AK; Ling DC; Vargo JA; Orr BC; Sukumvanich P; Courtney-Brooks MB; Boisen MM; Berger JL; Taylor S; Olawaiye AB; Comerci JT; Lesnock JL; Edwards RP; Beriwal S
Gynecol Oncol; 2020 Oct; 159(1):23-29. PubMed ID: 32718729
[TBL] [Abstract][Full Text] [Related]
8. Association of Lymphovascular Space Invasion (LVSI) with Histological Tumor Grade and Myometrial Invasion in Endometrial Carcinoma: A Review Study.
Rafiee A; Mohammadizadeh F
Adv Biomed Res; 2023; 12():159. PubMed ID: 37564444
[TBL] [Abstract][Full Text] [Related]
9. Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Koirala N; Gaster K; Espaillat LR; Starks D; Dey N
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446260
[TBL] [Abstract][Full Text] [Related]
10. Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Vaselaar E; Ageton C; Gaster K; Espaillat LR; Starks D; Dey N
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230499
[TBL] [Abstract][Full Text] [Related]
11. A Laboratory-Friendly CTC Identification: Comparable Double-Immunocytochemistry with Triple-Immunofluorescence.
Sulaiman R; De P; Aske JC; Lin X; Dale A; Vaselaar E; Koirala N; Ageton C; Gaster K; Plorde J; Solomon B; Thaemert B; Meyer P; Espaillat LR; Starks D; Dey N
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740537
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.
Raffone A; Travaglino A; Raimondo D; Neola D; Maletta M; Santoro A; Insabato L; Casadio P; Fanfani F; Zannoni GF; Zullo F; Seracchioli R; Mollo A
Gynecol Oncol; 2022 Apr; 165(1):192-197. PubMed ID: 35078650
[TBL] [Abstract][Full Text] [Related]
13. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
